Salwa Naushin

Institute of Genomics and Integrative Biology — India

Medicine · Health Sciences

10h-index726citations19works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(13), COVID-19 Clinical Research Studies(7), SARS-CoV-2 detection and testing(6), COVID-19 epidemiological studies(5), Advanced Proteomics Techniques and Applications(3)

Publications19 total

A High Throughput Lipidomics Method Using Scheduled Multiple Reaction Monitoring
Biomolecules·2022· 24 citedOpen Access
A machine learning-based approach to determine infection status in recipients of BBV152 (Covaxin) whole-virion inactivated SARS-CoV-2 vaccine for serological surveys
Computers in Biology and Medicine·2022· 15 citedOpen Access
High failure rate of ChAdOx1-nCoV19 immunization against asymptomatic infection in healthcare workers during a Delta variant surge
Nature Communications·2022· 10 citedOpen Access
A machine learning-based approach to determine infection status in recipients of BBV152 whole virion inactivated SARS-CoV-2 vaccine for serological surveys
2021Open Access
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Science·2021· 311 citedOpen Access
Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
2021· 100 citedOpen Access
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2
eLife·2021· 28 citedOpen Access
Author response: Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2
2021· 2 citedOpen Access
High failure rate of ChAdOx1 in healthcare workers during Delta variant surge: A case for continued use of masks post-vaccination
2021· 2 citedOpen Access
High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing
PLoS ONE·2021· 150 citedOpen Access
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV-2
2021· 6 citedOpen Access
A high throughput lipidomics method using <i>scheduled</i> multiple reaction monitoring
2021· 2 citedOpen Access
Issue Information
Human Mutation·2020Open Access
Frequency spectrum of rare and clinically relevant markers in multiethnic Indian populations (ClinIndb): A resource for genomic medicine in India
Human Mutation·2020· 14 cited
“SARS-CoV-2 antibody seroprevalence and stability in a tertiary care hospital-setting”
2020· 10 citedOpen Access
High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next generation sequencing
2020· 40 citedOpen Access
Frequency spectrum of rare and clinically relevant markers in multi-ethnic Indian populations (ClinIndb): A resource for genomic medicine in India
Authorea·2020· 1 citedOpen Access
SARS-CoV-2 Antibody Seroprevalence and Stability in a Tertiary Care Hospital-Setting
SSRN Electronic Journal·2020· 6 citedOpen Access
Quantitative proteomics study reveals differential proteomic signature in dilated, restrictive, and hypertrophic cardiomyopathies
Journal of Proteins and Proteomics·2019· 5 cited

Frequent Co-authors

Shantanu Sengupta(12), Viren Sardana(9), Rajat Ujjainiya(9), Shalini Pradhan(9), Nitin Bhatheja(8), Akash Kumar Bhaskar(7), Satyartha Prakash(7), Mohammed Faruq(6), Karthik Bharadwaj Tallapaka(6), Pooja Sharma(5), Debasis Dash(5), Rintu Kutum(5), Raju Khan(5), Mahesh Anumalla(5), Amit Lahiri(5), S.K. Kar(5), Madhav Nilakanth Mugale(5), Mrigank Srivastava(5), Shaziya Khan(5), Murugan Veerapandian(5)